626 related articles for article (PubMed ID: 24320423)
1. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
2. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
3. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of patient DVH-based QA metrics for prostate VMAT: correlation between accuracy of estimated 3D patient dose and magnitude of MLC misalignment.
Kadoya N; Saito M; Ogasawara M; Fujita Y; Ito K; Sato K; Kishi K; Dobashi S; Takeda K; Jingu K
J Appl Clin Med Phys; 2015 May; 16(3):5251. PubMed ID: 26103486
[TBL] [Abstract][Full Text] [Related]
5. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
6. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
7. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
[TBL] [Abstract][Full Text] [Related]
8. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
9. Quantification of residual dose estimation error on log file-based patient dose calculation.
Katsuta Y; Kadoya N; Fujita Y; Shimizu E; Matsunaga K; Matsushita H; Majima K; Jingu K
Phys Med; 2016 May; 32(5):701-5. PubMed ID: 27162084
[TBL] [Abstract][Full Text] [Related]
10. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
11. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
12. 3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification.
Carrasco P; Jornet N; Latorre A; Eudaldo T; Ruiz A; Ribas M
Med Phys; 2012 Aug; 39(8):5040-9. PubMed ID: 22894429
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant quality assurance (QA) for prostate RapidArc plans: gamma maps and DVH-based evaluation.
Cozzolino M; Oliviero C; Califano G; Clemente S; Pedicini P; Caivano R; Chiumento C; Fiorentino A; Fusco V
Phys Med; 2014 Jun; 30(4):462-72. PubMed ID: 24480527
[TBL] [Abstract][Full Text] [Related]
14. Impact of the MLC leaf-tip model in a commercial TPS: Dose calculation limitations and IROC-H phantom failures.
Koger B; Price R; Wang D; Toomeh D; Geneser S; Ford E
J Appl Clin Med Phys; 2020 Feb; 21(2):82-88. PubMed ID: 31961036
[TBL] [Abstract][Full Text] [Related]
15. Online adaptation and verification of VMAT.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
17. Incorrect dosimetric leaf separation in IMRT and VMAT treatment planning: Clinical impact and correlation with pretreatment quality assurance.
Sjölin M; Edmund JM
Phys Med; 2016 Jul; 32(7):918-25. PubMed ID: 27394690
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance for online adapted treatment plans: benchmarking and delivery monitoring simulation.
Li T; Wu Q; Yang Y; Rodrigues A; Yin FF; Jackie Wu Q
Med Phys; 2015 Jan; 42(1):381-90. PubMed ID: 25563278
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
20. Utilizing knowledge from prior plans in the evaluation of quality assurance.
Stanhope C; Wu QJ; Yuan L; Liu J; Hood R; Yin FF; Adamson J
Phys Med Biol; 2015 Jun; 60(12):4873-91. PubMed ID: 26056801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
